Sumitomo Pharma Co., Ltd.
4506.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | ¥87,654 | ¥11,206 | ¥2,415 | ¥53,448 |
| Dep. & Amort. | ¥5,278 | ¥5,203 | ¥5,807 | ¥6,066 |
| Deferred Tax | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock-Based Comp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Change in WC | -¥19,550 | -¥17,430 | -¥733 | ¥183 |
| Other Non-Cash | -¥55,165 | ¥829 | ¥3,520 | -¥58,758 |
| Operating Cash Flow | ¥18,217 | -¥192 | ¥11,009 | ¥939 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -¥1,559 | -¥2,451 | -¥2,375 | -¥2,057 |
| Net Acquisitions | ¥30,473 | -¥1,954 | ¥539 | -¥539 |
| Inv. Purchases | -¥324 | -¥462 | ¥0 | ¥0 |
| Inv. Sales/Matur. | ¥3,326 | ¥108 | ¥0 | ¥0 |
| Other Inv. Act. | ¥32 | ¥445 | ¥4,147 | ¥2,588 |
| Investing Cash Flow | ¥31,948 | -¥4,314 | ¥2,311 | -¥8 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -¥46,500 | ¥3,970 | -¥28,271 | -¥15,000 |
| Stock Issued | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock Repurch. | ¥0 | ¥0 | ¥0 | ¥0 |
| Dividends Paid | ¥0 | -¥1 | -¥1 | -¥1 |
| Other Fin. Act. | -¥688 | -¥750 | -¥35,263 | -¥864 |
| Financing Cash Flow | -¥47,188 | ¥3,219 | -¥63,535 | -¥15,865 |
| Forex Effect | ¥15,060 | -¥1,376 | -¥12,062 | ¥1,245 |
| Net Chg. in Cash | ¥18,037 | -¥2,663 | -¥62,277 | -¥13,689 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | ¥20,453 | ¥23,116 | ¥85,393 | ¥99,082 |
| End Cash | ¥38,490 | ¥20,453 | ¥23,116 | ¥85,393 |
| Free Cash Flow | ¥17,168 | -¥1,666 | ¥8,634 | -¥1,118 |